ストックスクリーナーアプリを入手
16.72
1.09%
0.18
プレマーケット:
16.74
0.02
+0.12%
前日終値:
$16.54
開ける：
$16.585
24時間の取引高:
8.29M
Relative Volume:
0.84
時価総額：
$19.20B
収益：
$14.57B
当期純損益:
$-296.50M
株価収益率:
-64.56
EPS:
-0.259
ネットキャッシュフロー:
$1.64B
1週間 パフォーマンス:
+3.40%
1か月 パフォーマンス:
-3.02%
6か月 パフォーマンス:
+3.98%
1年 パフォーマンス:
+58.48%
1日の値動き範囲:
$16.44
$16.74
1週間の範囲:
$15.98
$16.74
52週間の値動き範囲:
$9.425
$18.39
Viatris Inc Stock (VTRS) Company Profile
Compare VTRS vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
16.72 | 18.52B | 14.57B | -296.50M | 1.64B | -0.259 |
TAK
Takeda Pharmaceutical Co Adr
|
18.35 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.18 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
38.10 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.29 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
518.53 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-09 | アップグレード | UBS | Neutral → Buy |
| 2026-01-16 | アップグレード | Argus | Hold → Buy |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-15 | 開始されました | Truist | Buy |
| 2025-06-06 | 開始されました | Goldman | Neutral |
| 2024-07-19 | 再開されました | Jefferies | Buy |
| 2023-10-23 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-06-23 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2023-04-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2023-02-17 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-10 | アップグレード | UBS | Sell → Neutral |
| 2022-11-08 | アップグレード | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | 再開されました | Jefferies | Hold |
| 2022-06-14 | 開始されました | UBS | Sell |
| 2022-05-10 | ダウングレード | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-01 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | 開始されました | Citigroup | Neutral |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2021-03-08 | ダウングレード | Goldman | Buy → Neutral |
| 2021-03-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-02-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | 開始されました | Argus | Hold |
| 2020-12-14 | 開始されました | Bernstein | Mkt Perform |
すべてを表示
Viatris Inc (VTRS) 最新ニュース
Viatris (VTRS) Q1 2026 Earnings Call Transcript - Fortune
Viatris (VTRS) Q4 2025 Earnings Call Transcript - Fortune
Viatris' China Policy Concerns Overstated, UBS Says - Moomoo
Barclays Maintains Viatris(VTRS.US) With Buy Rating, Maintains Target Price $22 - Moomoo
Viatris Inc. (VTRS) Stock Analysis: Healthcare Giant with a 13.99% Upside and Strategic Collaborations - DirectorsTalk Interviews
5 Must-Read Analyst Questions From Viatris’s Q2 Earnings Call - Yahoo Finance
Viatris Inc. stock rises Friday, outperforms market - MarketWatch
Viatris Inc (VTRS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
Viatris Inc. (VTRS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine? - Yahoo Finance
Viatris Inc. stock falls Wednesday, underperforms market - MarketWatch
Davis Selected Advisers (VTRS) discloses 75.2M-share, 6.5% stake in Viatris Inc - Stock Titan
ETFs Investing in Viatris, Inc. Stocks - TradingView
TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks - TradingView
Harrow adds TYRVAYA's global rights to dry eye portfolio - Glance by Eyes On Eyecare
Viatris (VTRS) Stock Trades At A Discount To Sales Despite A 76% Run - Sahm
Theravance Biopharma Q2 2026: Viatris collaboration revenue $20.7M; net loss $5.9M; $388M cash - TradingView
Viatris Inc. (VTRS) Stock Analysis: Unveiling a 12.6% Potential Upside Amidst Strong Cash Flow - DirectorsTalk Interviews
Why Viatris (VTRS) Is Down 6.4% After Boosting Guidance And Completing A $1.15 Billion Buyback - simplywall.st
Viatris (VTRS) Is Down 6.4% After Raising 2026 Guidance And Completing Major Buyback Program - finance.yahoo.com
Viatris (VTRS) Stock May Be Below Fair Value Despite FDA Patch Approval - Yahoo Finance
Viatris (VTRS) Stock Sees Modest Fair Value Lift After Q1 Results And Pipeline Progress - Yahoo Finance
Viatris Inc. (VTRS) Stock Forecasts - Yahoo! Finance Canada
Viatris (VTRS) Raises 2026 Guidance, Is The 11% Gap Below Fair Value Enough? - Yahoo Finance
Viatris (VTRS) Stock Looks Stuck Between Higher Guidance And Wider Losses - Sahm
Viatris Inc. (US92556V1061.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Viatris Inc. Stock Sheds 7.7%, Underperforms Market - webull.com
Viatris Earnings: Good Performance in Key Regions and Outlook Increase Make for a Solid Quarter - Morningstar
Harrow Enters Agreement to Acquire Tyrvaya Dry Eye Treatment From Viatris Inc. - VisionMonday.com
Viatris Inc. Stock 12‑Month Price Target Raised to $18.71, Implies 6% Upside - TradingView
Viatris Inc (VTRS) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance Amid ... - Yahoo Finance
Viatris Inc (VTRS) Shares Fall 7.6% -- GF Value Says Still Overv - GuruFocus
Viatris Inc. stock falls Thursday, underperforms market - MarketWatch
Viatris Inc Q2 2026: Revenue $3.76B, EPS $(0.10) — 10-Q Summary - TradingView
Viatris (NASDAQ: VTRS) swings to H1 2026 profit as revenue tops $7.27B - Stock Titan
Tranche Update on Viatris Inc.'s Equity Buyback Plan announced on February 28, 2022. - marketscreener.com
Viatris Q2 2026 slides: strong beat, raised outlook, H2 headwinds - Investing.com
Viatris Q2 2026 slides: strong results lift guidance amid H2 headwinds - Investing.com
Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook - TradingView
Viatris Looks to New Launches, Pipeline Progression, and Cost Savings for Long-Term Growth - Morningstar
Viatris Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:VTRS) 2026-08-06 - Seeking Alpha
Viatris stock hits 52-week high at 18.27 USD - Investing.com
Viatris Q2 2026 slides: strong beat drives guidance raise - Investing.com
FMR LLC discloses 8.3% Viatris Inc (VTRS) ownership, over 96M shares - Stock Titan
Earnings call transcript: Viatris tops Q2 2026 estimates, lifts outlook - Investing.com
Viatris Announces Quarterly Dividend - marketscreener.com
Viatris Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Viatris Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
VIATRIS INC (VTRS.VI) Q2 FY2026 earnings call transcript - Yahoo Finance
Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Viatris Inc (VTRS) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
大文字化:
|
ボリューム (24 時間):